Health
Novo Nordisk Drug Fails Heart Disease Trial
A Novo Nordisk drug failed to show effectiveness in a heart disease study, prompting questions about inflammation-targeted treatments.
Coverage timeline — 1 article
STAT News
A Novo Nordisk drug missed the mark in a heart disease study, raising questions about targeting inflammation to prevent cardiovascular complications.
2026-07-31 12:32 UTC